March 22, 2024, 4:42 a.m. | Xiangxin Zhou, Xiwei Cheng, Yuwei Yang, Yu Bao, Liang Wang, Quanquan Gu

cs.LG updates on arXiv.org arxiv.org

arXiv:2403.13829v1 Announce Type: cross
Abstract: Recently, 3D generative models have shown promising performances in structure-based drug design by learning to generate ligands given target binding sites. However, only modeling the target-ligand distribution can hardly fulfill one of the main goals in drug discovery -- designing novel ligands with desired properties, e.g., high binding affinity, easily synthesizable, etc. This challenge becomes particularly pronounced when the target-ligand pairs used for training do not align with these desired properties. Moreover, most existing methods …

abstract arxiv cs.lg design designing diffusion diffusion models discovery distribution drug design drug discovery generate generative generative models however modeling novel optimization performances q-bio.bm type

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Senior ML Engineer

@ Carousell Group | Ho Chi Minh City, Vietnam

Data and Insight Analyst

@ Cotiviti | Remote, United States